nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—metabolic syndrome X—atherosclerosis	0.599	0.775	CtDrD
Metformin—type 2 diabetes mellitus—atherosclerosis	0.174	0.225	CtDrD
Metformin—NDUFAF4—Simvastatin—Pravastatin—atherosclerosis	0.00138	0.5	CbGdCrCtD
Metformin—NDUFAF4—Simvastatin—Lovastatin—atherosclerosis	0.00138	0.5	CbGdCrCtD
Metformin—NDUFV3—cardiovascular system—atherosclerosis	0.000883	0.0127	CbGeAlD
Metformin—NDUFS6—cardiovascular system—atherosclerosis	0.000859	0.0123	CbGeAlD
Metformin—NDUFA1—connective tissue—atherosclerosis	0.000792	0.0114	CbGeAlD
Metformin—NDUFAF3—cardiovascular system—atherosclerosis	0.000781	0.0112	CbGeAlD
Metformin—NDUFV2—connective tissue—atherosclerosis	0.000769	0.011	CbGeAlD
Metformin—NDUFA7—adipose tissue—atherosclerosis	0.000738	0.0106	CbGeAlD
Metformin—SLC29A4—adipose tissue—atherosclerosis	0.000704	0.0101	CbGeAlD
Metformin—NDUFA13—cardiovascular system—atherosclerosis	0.0007	0.01	CbGeAlD
Metformin—NDUFA9—cardiovascular system—atherosclerosis	0.0007	0.01	CbGeAlD
Metformin—NDUFA1—cardiovascular system—atherosclerosis	0.000689	0.00988	CbGeAlD
Metformin—NDUFV2—cardiovascular system—atherosclerosis	0.000669	0.00959	CbGeAlD
Metformin—ND5—cardiovascular system—atherosclerosis	0.000612	0.00877	CbGeAlD
Metformin—ND2—cardiovascular system—atherosclerosis	0.000612	0.00877	CbGeAlD
Metformin—ND3—cardiovascular system—atherosclerosis	0.000612	0.00877	CbGeAlD
Metformin—ND4L—cardiovascular system—atherosclerosis	0.000612	0.00877	CbGeAlD
Metformin—NDUFA1—adipose tissue—atherosclerosis	0.000608	0.00871	CbGeAlD
Metformin—NDUFA5—connective tissue—atherosclerosis	0.000596	0.00854	CbGeAlD
Metformin—ND4—cardiovascular system—atherosclerosis	0.000592	0.00849	CbGeAlD
Metformin—NDUFAF4—connective tissue—atherosclerosis	0.000591	0.00848	CbGeAlD
Metformin—NDUFV2—adipose tissue—atherosclerosis	0.00059	0.00846	CbGeAlD
Metformin—NDUFS1—connective tissue—atherosclerosis	0.000587	0.00842	CbGeAlD
Metformin—NDUFB10—connective tissue—atherosclerosis	0.000583	0.00836	CbGeAlD
Metformin—NDUFA2—cardiovascular system—atherosclerosis	0.00058	0.00832	CbGeAlD
Metformin—NDUFA4L2—adipose tissue—atherosclerosis	0.000574	0.00823	CbGeAlD
Metformin—NDUFA6—connective tissue—atherosclerosis	0.000567	0.00813	CbGeAlD
Metformin—NDUFS4—connective tissue—atherosclerosis	0.000563	0.00808	CbGeAlD
Metformin—NDUFB4—connective tissue—atherosclerosis	0.000556	0.00797	CbGeAlD
Metformin—NDUFA10—cardiovascular system—atherosclerosis	0.000553	0.00794	CbGeAlD
Metformin—NDUFAB1—connective tissue—atherosclerosis	0.000552	0.00792	CbGeAlD
Metformin—NDUFB9—connective tissue—atherosclerosis	0.000549	0.00787	CbGeAlD
Metformin—NDUFC1—cardiovascular system—atherosclerosis	0.000548	0.00787	CbGeAlD
Metformin—NDUFV3—liver—atherosclerosis	0.000546	0.00783	CbGeAlD
Metformin—NDUFB2—cardiovascular system—atherosclerosis	0.000544	0.0078	CbGeAlD
Metformin—NDUFV1—connective tissue—atherosclerosis	0.000542	0.00778	CbGeAlD
Metformin—NDUFB8—connective tissue—atherosclerosis	0.000539	0.00773	CbGeAlD
Metformin—NDUFS5—connective tissue—atherosclerosis	0.000539	0.00773	CbGeAlD
Metformin—ND6—cardiovascular system—atherosclerosis	0.000535	0.00767	CbGeAlD
Metformin—NDUFS6—liver—atherosclerosis	0.000531	0.00762	CbGeAlD
Metformin—NDUFB3—cardiovascular system—atherosclerosis	0.00053	0.00761	CbGeAlD
Metformin—NDUFA5—cardiovascular system—atherosclerosis	0.000518	0.00743	CbGeAlD
Metformin—NDUFA11—cardiovascular system—atherosclerosis	0.000518	0.00743	CbGeAlD
Metformin—NDUFA7—liver—atherosclerosis	0.000517	0.00742	CbGeAlD
Metformin—NDUFB6—cardiovascular system—atherosclerosis	0.000514	0.00738	CbGeAlD
Metformin—NDUFAF4—cardiovascular system—atherosclerosis	0.000514	0.00738	CbGeAlD
Metformin—NDUFA2—adipose tissue—atherosclerosis	0.000511	0.00734	CbGeAlD
Metformin—NDUFS1—cardiovascular system—atherosclerosis	0.000511	0.00732	CbGeAlD
Metformin—NDUFB10—cardiovascular system—atherosclerosis	0.000507	0.00727	CbGeAlD
Metformin—NDUFS7—connective tissue—atherosclerosis	0.000505	0.00725	CbGeAlD
Metformin—NDUFA12—cardiovascular system—atherosclerosis	0.000503	0.00722	CbGeAlD
Metformin—NDUFB7—cardiovascular system—atherosclerosis	0.000503	0.00722	CbGeAlD
Metformin—NDUFB1—cardiovascular system—atherosclerosis	0.0005	0.00717	CbGeAlD
Metformin—NDUFS8—cardiovascular system—atherosclerosis	0.0005	0.00717	CbGeAlD
Metformin—SLC29A4—liver—atherosclerosis	0.000494	0.00708	CbGeAlD
Metformin—NDUFA6—cardiovascular system—atherosclerosis	0.000493	0.00707	CbGeAlD
Metformin—NDUFB5—cardiovascular system—atherosclerosis	0.000493	0.00707	CbGeAlD
Metformin—NDUFS4—cardiovascular system—atherosclerosis	0.00049	0.00703	CbGeAlD
Metformin—NDUFA10—adipose tissue—atherosclerosis	0.000488	0.007	CbGeAlD
Metformin—NDUFC1—adipose tissue—atherosclerosis	0.000484	0.00694	CbGeAlD
Metformin—NDUFB4—cardiovascular system—atherosclerosis	0.000484	0.00694	CbGeAlD
Metformin—NDUFAF3—liver—atherosclerosis	0.000483	0.00693	CbGeAlD
Metformin—NDUFAB1—cardiovascular system—atherosclerosis	0.000481	0.00689	CbGeAlD
Metformin—NDUFB2—adipose tissue—atherosclerosis	0.000479	0.00688	CbGeAlD
Metformin—NDUFA8—cardiovascular system—atherosclerosis	0.000478	0.00685	CbGeAlD
Metformin—NDUFB9—cardiovascular system—atherosclerosis	0.000478	0.00685	CbGeAlD
Metformin—NDUFAF1—adipose tissue—atherosclerosis	0.000475	0.00682	CbGeAlD
Metformin—NDUFA4—cardiovascular system—atherosclerosis	0.000475	0.00681	CbGeAlD
Metformin—NDUFB11—cardiovascular system—atherosclerosis	0.000472	0.00677	CbGeAlD
Metformin—NDUFV1—cardiovascular system—atherosclerosis	0.000472	0.00677	CbGeAlD
Metformin—NDUFS5—cardiovascular system—atherosclerosis	0.000469	0.00673	CbGeAlD
Metformin—NDUFB8—cardiovascular system—atherosclerosis	0.000469	0.00673	CbGeAlD
Metformin—NDUFAF2—adipose tissue—atherosclerosis	0.000468	0.00671	CbGeAlD
Metformin—NDUFB3—adipose tissue—atherosclerosis	0.000468	0.00671	CbGeAlD
Metformin—NDUFA5—adipose tissue—atherosclerosis	0.000457	0.00655	CbGeAlD
Metformin—NDUFA11—adipose tissue—atherosclerosis	0.000457	0.00655	CbGeAlD
Metformin—NDUFAF4—adipose tissue—atherosclerosis	0.000454	0.00651	CbGeAlD
Metformin—NDUFB6—adipose tissue—atherosclerosis	0.000454	0.00651	CbGeAlD
Metformin—NDUFS1—adipose tissue—atherosclerosis	0.00045	0.00646	CbGeAlD
Metformin—NDUFB10—adipose tissue—atherosclerosis	0.000447	0.00641	CbGeAlD
Metformin—NDUFB7—adipose tissue—atherosclerosis	0.000444	0.00637	CbGeAlD
Metformin—NDUFA12—adipose tissue—atherosclerosis	0.000444	0.00637	CbGeAlD
Metformin—NDUFB1—adipose tissue—atherosclerosis	0.000441	0.00632	CbGeAlD
Metformin—NDUFS8—adipose tissue—atherosclerosis	0.000441	0.00632	CbGeAlD
Metformin—NDUFS7—cardiovascular system—atherosclerosis	0.00044	0.0063	CbGeAlD
Metformin—NDUFB5—adipose tissue—atherosclerosis	0.000435	0.00624	CbGeAlD
Metformin—NDUFA6—adipose tissue—atherosclerosis	0.000435	0.00624	CbGeAlD
Metformin—NDUFA9—liver—atherosclerosis	0.000433	0.00621	CbGeAlD
Metformin—NDUFA13—liver—atherosclerosis	0.000433	0.00621	CbGeAlD
Metformin—NDUFS4—adipose tissue—atherosclerosis	0.000432	0.0062	CbGeAlD
Metformin—NDUFB4—adipose tissue—atherosclerosis	0.000426	0.00612	CbGeAlD
Metformin—NDUFA1—liver—atherosclerosis	0.000426	0.00611	CbGeAlD
Metformin—NDUFAB1—adipose tissue—atherosclerosis	0.000424	0.00608	CbGeAlD
Metformin—NDUFA8—adipose tissue—atherosclerosis	0.000421	0.00604	CbGeAlD
Metformin—NDUFB9—adipose tissue—atherosclerosis	0.000421	0.00604	CbGeAlD
Metformin—NDUFA4—adipose tissue—atherosclerosis	0.000419	0.006	CbGeAlD
Metformin—NDUFS2—connective tissue—atherosclerosis	0.000419	0.006	CbGeAlD
Metformin—NDUFV1—adipose tissue—atherosclerosis	0.000416	0.00597	CbGeAlD
Metformin—NDUFB11—adipose tissue—atherosclerosis	0.000416	0.00597	CbGeAlD
Metformin—NDUFV2—liver—atherosclerosis	0.000414	0.00593	CbGeAlD
Metformin—NDUFB8—adipose tissue—atherosclerosis	0.000414	0.00593	CbGeAlD
Metformin—NDUFS5—adipose tissue—atherosclerosis	0.000414	0.00593	CbGeAlD
Metformin—NDUFS3—connective tissue—atherosclerosis	0.000413	0.00593	CbGeAlD
Metformin—NDUFS7—adipose tissue—atherosclerosis	0.000388	0.00556	CbGeAlD
Metformin—Hepatitis—Rosuvastatin—atherosclerosis	0.000382	0.005	CcSEcCtD
Metformin—NDUFC2—cardiovascular system—atherosclerosis	0.000379	0.00543	CbGeAlD
Metformin—ND5—liver—atherosclerosis	0.000378	0.00543	CbGeAlD
Metformin—ND3—liver—atherosclerosis	0.000378	0.00543	CbGeAlD
Metformin—ND2—liver—atherosclerosis	0.000378	0.00543	CbGeAlD
Metformin—ND4L—liver—atherosclerosis	0.000378	0.00543	CbGeAlD
Metformin—Liver function test abnormal—Niacin—atherosclerosis	0.000371	0.00485	CcSEcCtD
Metformin—Pancreatitis—Simvastatin—atherosclerosis	0.000371	0.00485	CcSEcCtD
Metformin—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000369	0.00482	CcSEcCtD
Metformin—ND4—liver—atherosclerosis	0.000366	0.00525	CbGeAlD
Metformin—Liver function test abnormal—Pravastatin—atherosclerosis	0.000365	0.00478	CcSEcCtD
Metformin—NDUFS2—cardiovascular system—atherosclerosis	0.000364	0.00522	CbGeAlD
Metformin—Abdominal discomfort—Simvastatin—atherosclerosis	0.000363	0.00474	CcSEcCtD
Metformin—NDUFS3—cardiovascular system—atherosclerosis	0.00036	0.00516	CbGeAlD
Metformin—NDUFA2—liver—atherosclerosis	0.000359	0.00514	CbGeAlD
Metformin—Cramp muscle—Pravastatin—atherosclerosis	0.000356	0.00466	CcSEcCtD
Metformin—PRKAB1—adipose tissue—atherosclerosis	0.000354	0.00508	CbGeAlD
Metformin—Nasopharyngitis—Pravastatin—atherosclerosis	0.000354	0.00463	CcSEcCtD
Metformin—Infestation—Ezetimibe—atherosclerosis	0.000354	0.00463	CcSEcCtD
Metformin—Infestation NOS—Ezetimibe—atherosclerosis	0.000354	0.00463	CcSEcCtD
Metformin—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000353	0.00462	CcSEcCtD
Metformin—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000351	0.0046	CcSEcCtD
Metformin—Abdominal distension—Niacin—atherosclerosis	0.00035	0.00457	CcSEcCtD
Metformin—Influenza—Niacin—atherosclerosis	0.000347	0.00454	CcSEcCtD
Metformin—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000347	0.00453	CcSEcCtD
Metformin—Abdominal distension—Pravastatin—atherosclerosis	0.000344	0.0045	CcSEcCtD
Metformin—NDUFA10—liver—atherosclerosis	0.000342	0.00491	CbGeAlD
Metformin—Influenza—Pravastatin—atherosclerosis	0.000342	0.00447	CcSEcCtD
Metformin—NDUFC1—liver—atherosclerosis	0.000339	0.00486	CbGeAlD
Metformin—Angina pectoris—Niacin—atherosclerosis	0.000338	0.00443	CcSEcCtD
Metformin—NDUFB2—liver—atherosclerosis	0.000336	0.00482	CbGeAlD
Metformin—Pancreatitis—Pravastatin—atherosclerosis	0.000335	0.00439	CcSEcCtD
Metformin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000334	0.00437	CcSEcCtD
Metformin—NDUFC2—adipose tissue—atherosclerosis	0.000334	0.00479	CbGeAlD
Metformin—NDUFAF1—liver—atherosclerosis	0.000333	0.00478	CbGeAlD
Metformin—Angina pectoris—Pravastatin—atherosclerosis	0.000333	0.00436	CcSEcCtD
Metformin—Sweating increased—Pravastatin—atherosclerosis	0.000333	0.00436	CcSEcCtD
Metformin—ND6—liver—atherosclerosis	0.000331	0.00474	CbGeAlD
Metformin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000331	0.00432	CcSEcCtD
Metformin—NDUFAF2—liver—atherosclerosis	0.000328	0.0047	CbGeAlD
Metformin—NDUFB3—liver—atherosclerosis	0.000328	0.0047	CbGeAlD
Metformin—Flatulence—Rosuvastatin—atherosclerosis	0.000328	0.00429	CcSEcCtD
Metformin—Hepatitis—Lovastatin—atherosclerosis	0.000324	0.00423	CcSEcCtD
Metformin—NDUFS2—adipose tissue—atherosclerosis	0.000321	0.00461	CbGeAlD
Metformin—NDUFA11—liver—atherosclerosis	0.00032	0.0046	CbGeAlD
Metformin—NDUFA5—liver—atherosclerosis	0.00032	0.0046	CbGeAlD
Metformin—NDUFB6—liver—atherosclerosis	0.000318	0.00456	CbGeAlD
Metformin—NDUFAF4—liver—atherosclerosis	0.000318	0.00456	CbGeAlD
Metformin—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000318	0.00416	CcSEcCtD
Metformin—Hepatitis—Ezetimibe—atherosclerosis	0.000317	0.00415	CcSEcCtD
Metformin—NDUFS3—adipose tissue—atherosclerosis	0.000317	0.00455	CbGeAlD
Metformin—NDUFS1—liver—atherosclerosis	0.000316	0.00453	CbGeAlD
Metformin—NDUFB10—liver—atherosclerosis	0.000313	0.0045	CbGeAlD
Metformin—Oedema peripheral—Ezetimibe—atherosclerosis	0.000313	0.00409	CcSEcCtD
Metformin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000312	0.00408	CcSEcCtD
Metformin—NDUFB7—liver—atherosclerosis	0.000311	0.00446	CbGeAlD
Metformin—NDUFA12—liver—atherosclerosis	0.000311	0.00446	CbGeAlD
Metformin—NDUFB1—liver—atherosclerosis	0.000309	0.00443	CbGeAlD
Metformin—NDUFS8—liver—atherosclerosis	0.000309	0.00443	CbGeAlD
Metformin—NDUFB5—liver—atherosclerosis	0.000305	0.00437	CbGeAlD
Metformin—NDUFA6—liver—atherosclerosis	0.000305	0.00437	CbGeAlD
Metformin—NDUFS4—liver—atherosclerosis	0.000303	0.00435	CbGeAlD
Metformin—Hepatitis—Simvastatin—atherosclerosis	0.000303	0.00396	CcSEcCtD
Metformin—Flushing—Lovastatin—atherosclerosis	0.0003	0.00393	CcSEcCtD
Metformin—NDUFB4—liver—atherosclerosis	0.000299	0.00429	CbGeAlD
Metformin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000299	0.00391	CcSEcCtD
Metformin—ND1—cardiovascular system—atherosclerosis	0.000299	0.00429	CbGeAlD
Metformin—NDUFAB1—liver—atherosclerosis	0.000297	0.00426	CbGeAlD
Metformin—NDUFA8—liver—atherosclerosis	0.000295	0.00424	CbGeAlD
Metformin—NDUFB9—liver—atherosclerosis	0.000295	0.00424	CbGeAlD
Metformin—Flushing—Ezetimibe—atherosclerosis	0.000295	0.00385	CcSEcCtD
Metformin—NDUFA4—liver—atherosclerosis	0.000294	0.00421	CbGeAlD
Metformin—NDUFV1—liver—atherosclerosis	0.000292	0.00419	CbGeAlD
Metformin—NDUFB11—liver—atherosclerosis	0.000292	0.00419	CbGeAlD
Metformin—Chills—Lovastatin—atherosclerosis	0.00029	0.0038	CcSEcCtD
Metformin—NDUFS5—liver—atherosclerosis	0.00029	0.00416	CbGeAlD
Metformin—NDUFB8—liver—atherosclerosis	0.00029	0.00416	CbGeAlD
Metformin—Angiopathy—Ezetimibe—atherosclerosis	0.000288	0.00377	CcSEcCtD
Metformin—Immune system disorder—Ezetimibe—atherosclerosis	0.000287	0.00375	CcSEcCtD
Metformin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000286	0.00374	CcSEcCtD
Metformin—Myalgia—Rosuvastatin—atherosclerosis	0.000283	0.0037	CcSEcCtD
Metformin—Flushing—Simvastatin—atherosclerosis	0.000281	0.00368	CcSEcCtD
Metformin—Rhinitis—Niacin—atherosclerosis	0.000279	0.00365	CcSEcCtD
Metformin—Hepatitis—Niacin—atherosclerosis	0.000278	0.00364	CcSEcCtD
Metformin—Flatulence—Lovastatin—atherosclerosis	0.000278	0.00363	CcSEcCtD
Metformin—Hypoaesthesia—Niacin—atherosclerosis	0.000277	0.00362	CcSEcCtD
Metformin—Erythema—Ezetimibe—atherosclerosis	0.000276	0.00361	CcSEcCtD
Metformin—Malnutrition—Ezetimibe—atherosclerosis	0.000276	0.00361	CcSEcCtD
Metformin—Dysgeusia—Lovastatin—atherosclerosis	0.000276	0.00361	CcSEcCtD
Metformin—Rhinitis—Pravastatin—atherosclerosis	0.000274	0.00359	CcSEcCtD
Metformin—Oedema peripheral—Niacin—atherosclerosis	0.000274	0.00358	CcSEcCtD
Metformin—Hepatitis—Pravastatin—atherosclerosis	0.000274	0.00358	CcSEcCtD
Metformin—Hypoaesthesia—Pravastatin—atherosclerosis	0.000272	0.00356	CcSEcCtD
Metformin—Flatulence—Ezetimibe—atherosclerosis	0.000272	0.00356	CcSEcCtD
Metformin—NDUFS7—liver—atherosclerosis	0.000272	0.0039	CbGeAlD
Metformin—Chills—Simvastatin—atherosclerosis	0.000272	0.00355	CcSEcCtD
Metformin—Muscle spasms—Lovastatin—atherosclerosis	0.000271	0.00354	CcSEcCtD
Metformin—Infection—Rosuvastatin—atherosclerosis	0.00027	0.00353	CcSEcCtD
Metformin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000266	0.00348	CcSEcCtD
Metformin—Muscle spasms—Ezetimibe—atherosclerosis	0.000266	0.00348	CcSEcCtD
Metformin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000266	0.00348	CcSEcCtD
Metformin—Vision blurred—Lovastatin—atherosclerosis	0.000265	0.00347	CcSEcCtD
Metformin—Tremor—Lovastatin—atherosclerosis	0.000264	0.00345	CcSEcCtD
Metformin—Erythema—Simvastatin—atherosclerosis	0.000263	0.00345	CcSEcCtD
Metformin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000261	0.00342	CcSEcCtD
Metformin—Eye disorder—Niacin—atherosclerosis	0.00026	0.0034	CcSEcCtD
Metformin—Flatulence—Simvastatin—atherosclerosis	0.00026	0.0034	CcSEcCtD
Metformin—Dysgeusia—Simvastatin—atherosclerosis	0.000258	0.00338	CcSEcCtD
Metformin—Flushing—Niacin—atherosclerosis	0.000258	0.00337	CcSEcCtD
Metformin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000256	0.00335	CcSEcCtD
Metformin—Malaise—Lovastatin—atherosclerosis	0.000254	0.00332	CcSEcCtD
Metformin—Flushing—Pravastatin—atherosclerosis	0.000254	0.00332	CcSEcCtD
Metformin—Cardiac disorder—Pravastatin—atherosclerosis	0.000254	0.00332	CcSEcCtD
Metformin—Muscle spasms—Simvastatin—atherosclerosis	0.000253	0.00331	CcSEcCtD
Metformin—Angiopathy—Niacin—atherosclerosis	0.000252	0.0033	CcSEcCtD
Metformin—Chills—Niacin—atherosclerosis	0.000249	0.00326	CcSEcCtD
Metformin—Malaise—Ezetimibe—atherosclerosis	0.000249	0.00326	CcSEcCtD
Metformin—PRKAB1—liver—atherosclerosis	0.000249	0.00357	CbGeAlD
Metformin—Vision blurred—Simvastatin—atherosclerosis	0.000248	0.00325	CcSEcCtD
Metformin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000247	0.00323	CcSEcCtD
Metformin—Tremor—Simvastatin—atherosclerosis	0.000247	0.00323	CcSEcCtD
Metformin—Chills—Pravastatin—atherosclerosis	0.000246	0.00321	CcSEcCtD
Metformin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000244	0.0032	CcSEcCtD
Metformin—Palpitations—Ezetimibe—atherosclerosis	0.000244	0.00319	CcSEcCtD
Metformin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000244	0.00319	CcSEcCtD
Metformin—Malnutrition—Niacin—atherosclerosis	0.000242	0.00317	CcSEcCtD
Metformin—Erythema—Niacin—atherosclerosis	0.000242	0.00317	CcSEcCtD
Metformin—Chest pain—Lovastatin—atherosclerosis	0.00024	0.00314	CcSEcCtD
Metformin—Myalgia—Lovastatin—atherosclerosis	0.00024	0.00314	CcSEcCtD
Metformin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000239	0.00312	CcSEcCtD
Metformin—Hypertension—Ezetimibe—atherosclerosis	0.000239	0.00312	CcSEcCtD
Metformin—Flatulence—Niacin—atherosclerosis	0.000238	0.00312	CcSEcCtD
Metformin—Malaise—Simvastatin—atherosclerosis	0.000238	0.00311	CcSEcCtD
Metformin—Discomfort—Lovastatin—atherosclerosis	0.000237	0.0031	CcSEcCtD
Metformin—Chest pain—Ezetimibe—atherosclerosis	0.000235	0.00308	CcSEcCtD
Metformin—Myalgia—Ezetimibe—atherosclerosis	0.000235	0.00308	CcSEcCtD
Metformin—Flatulence—Pravastatin—atherosclerosis	0.000235	0.00307	CcSEcCtD
Metformin—NDUFC2—liver—atherosclerosis	0.000234	0.00336	CbGeAlD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000234	0.00306	CcSEcCtD
Metformin—Dysgeusia—Pravastatin—atherosclerosis	0.000233	0.00305	CcSEcCtD
Metformin—Muscle spasms—Niacin—atherosclerosis	0.000233	0.00304	CcSEcCtD
Metformin—Discomfort—Ezetimibe—atherosclerosis	0.000232	0.00304	CcSEcCtD
Metformin—Constipation—Rosuvastatin—atherosclerosis	0.000232	0.00304	CcSEcCtD
Metformin—Muscle spasms—Pravastatin—atherosclerosis	0.000229	0.003	CcSEcCtD
Metformin—Infection—Lovastatin—atherosclerosis	0.000228	0.00299	CcSEcCtD
Metformin—Vision blurred—Niacin—atherosclerosis	0.000228	0.00298	CcSEcCtD
Metformin—NDUFS2—liver—atherosclerosis	0.000225	0.00323	CbGeAlD
Metformin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000225	0.00295	CcSEcCtD
Metformin—Vision blurred—Pravastatin—atherosclerosis	0.000225	0.00294	CcSEcCtD
Metformin—Myalgia—Simvastatin—atherosclerosis	0.000224	0.00293	CcSEcCtD
Metformin—Chest pain—Simvastatin—atherosclerosis	0.000224	0.00293	CcSEcCtD
Metformin—Infection—Ezetimibe—atherosclerosis	0.000224	0.00293	CcSEcCtD
Metformin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000224	0.00292	CcSEcCtD
Metformin—Tremor—Pravastatin—atherosclerosis	0.000223	0.00292	CcSEcCtD
Metformin—NDUFS3—liver—atherosclerosis	0.000222	0.00319	CbGeAlD
Metformin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000222	0.0029	CcSEcCtD
Metformin—Discomfort—Simvastatin—atherosclerosis	0.000222	0.0029	CcSEcCtD
Metformin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000221	0.00289	CcSEcCtD
Metformin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000221	0.00289	CcSEcCtD
Metformin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000221	0.00289	CcSEcCtD
Metformin—Anorexia—Lovastatin—atherosclerosis	0.000219	0.00287	CcSEcCtD
Metformin—Skin disorder—Ezetimibe—atherosclerosis	0.000219	0.00287	CcSEcCtD
Metformin—Syncope—Niacin—atherosclerosis	0.000217	0.00284	CcSEcCtD
Metformin—Urticaria—Rosuvastatin—atherosclerosis	0.000216	0.00282	CcSEcCtD
Metformin—Oedema—Simvastatin—atherosclerosis	0.000215	0.00281	CcSEcCtD
Metformin—Malaise—Pravastatin—atherosclerosis	0.000215	0.00281	CcSEcCtD
Metformin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000214	0.00281	CcSEcCtD
Metformin—Palpitations—Niacin—atherosclerosis	0.000214	0.0028	CcSEcCtD
Metformin—Infection—Simvastatin—atherosclerosis	0.000214	0.0028	CcSEcCtD
Metformin—Loss of consciousness—Niacin—atherosclerosis	0.000213	0.00278	CcSEcCtD
Metformin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000211	0.00275	CcSEcCtD
Metformin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000209	0.00274	CcSEcCtD
Metformin—Paraesthesia—Lovastatin—atherosclerosis	0.000206	0.0027	CcSEcCtD
Metformin—Myalgia—Niacin—atherosclerosis	0.000206	0.00269	CcSEcCtD
Metformin—Hypertension—Pravastatin—atherosclerosis	0.000206	0.00269	CcSEcCtD
Metformin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000205	0.00269	CcSEcCtD
Metformin—Anorexia—Simvastatin—atherosclerosis	0.000205	0.00268	CcSEcCtD
Metformin—Dyspnoea—Lovastatin—atherosclerosis	0.000205	0.00268	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000205	0.00268	CcSEcCtD
Metformin—Myalgia—Pravastatin—atherosclerosis	0.000203	0.00265	CcSEcCtD
Metformin—Chest pain—Pravastatin—atherosclerosis	0.000203	0.00265	CcSEcCtD
Metformin—Paraesthesia—Ezetimibe—atherosclerosis	0.000202	0.00265	CcSEcCtD
Metformin—Dyspepsia—Lovastatin—atherosclerosis	0.000202	0.00265	CcSEcCtD
Metformin—Dyspnoea—Ezetimibe—atherosclerosis	0.000201	0.00263	CcSEcCtD
Metformin—Discomfort—Pravastatin—atherosclerosis	0.0002	0.00262	CcSEcCtD
Metformin—Decreased appetite—Lovastatin—atherosclerosis	0.0002	0.00261	CcSEcCtD
Metformin—Dyspepsia—Ezetimibe—atherosclerosis	0.000199	0.0026	CcSEcCtD
Metformin—Fatigue—Lovastatin—atherosclerosis	0.000198	0.00259	CcSEcCtD
Metformin—Oedema—Niacin—atherosclerosis	0.000197	0.00258	CcSEcCtD
Metformin—Constipation—Lovastatin—atherosclerosis	0.000197	0.00257	CcSEcCtD
Metformin—Decreased appetite—Ezetimibe—atherosclerosis	0.000196	0.00256	CcSEcCtD
Metformin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000196	0.00256	CcSEcCtD
Metformin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000195	0.00255	CcSEcCtD
Metformin—Asthenia—Rosuvastatin—atherosclerosis	0.000195	0.00255	CcSEcCtD
Metformin—Oedema—Pravastatin—atherosclerosis	0.000194	0.00254	CcSEcCtD
Metformin—Fatigue—Ezetimibe—atherosclerosis	0.000194	0.00254	CcSEcCtD
Metformin—Shock—Niacin—atherosclerosis	0.000194	0.00254	CcSEcCtD
Metformin—Infection—Pravastatin—atherosclerosis	0.000193	0.00253	CcSEcCtD
Metformin—Paraesthesia—Simvastatin—atherosclerosis	0.000193	0.00253	CcSEcCtD
Metformin—Constipation—Ezetimibe—atherosclerosis	0.000193	0.00252	CcSEcCtD
Metformin—Pruritus—Rosuvastatin—atherosclerosis	0.000192	0.00251	CcSEcCtD
Metformin—Skin disorder—Niacin—atherosclerosis	0.000192	0.00251	CcSEcCtD
Metformin—Dyspnoea—Simvastatin—atherosclerosis	0.000192	0.00251	CcSEcCtD
Metformin—Hyperhidrosis—Niacin—atherosclerosis	0.000191	0.0025	CcSEcCtD
Metformin—Thrombocytopenia—Pravastatin—atherosclerosis	0.00019	0.00249	CcSEcCtD
Metformin—Feeling abnormal—Lovastatin—atherosclerosis	0.000189	0.00248	CcSEcCtD
Metformin—Dyspepsia—Simvastatin—atherosclerosis	0.000189	0.00248	CcSEcCtD
Metformin—Anorexia—Niacin—atherosclerosis	0.000188	0.00246	CcSEcCtD
Metformin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000188	0.00246	CcSEcCtD
Metformin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000188	0.00246	CcSEcCtD
Metformin—Decreased appetite—Simvastatin—atherosclerosis	0.000187	0.00245	CcSEcCtD
Metformin—SLC22A3—connective tissue—atherosclerosis	0.000186	0.00267	CbGeAlD
Metformin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000186	0.00243	CcSEcCtD
Metformin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000186	0.00243	CcSEcCtD
Metformin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000186	0.00243	CcSEcCtD
Metformin—Fatigue—Simvastatin—atherosclerosis	0.000185	0.00243	CcSEcCtD
Metformin—Anorexia—Pravastatin—atherosclerosis	0.000185	0.00242	CcSEcCtD
Metformin—ND1—liver—atherosclerosis	0.000185	0.00265	CbGeAlD
Metformin—Hypotension—Niacin—atherosclerosis	0.000185	0.00241	CcSEcCtD
Metformin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000184	0.00241	CcSEcCtD
Metformin—Constipation—Simvastatin—atherosclerosis	0.000184	0.00241	CcSEcCtD
Metformin—Urticaria—Lovastatin—atherosclerosis	0.000183	0.00239	CcSEcCtD
Metformin—Abdominal pain—Lovastatin—atherosclerosis	0.000182	0.00238	CcSEcCtD
Metformin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00018	0.00235	CcSEcCtD
Metformin—Dizziness—Rosuvastatin—atherosclerosis	0.000179	0.00235	CcSEcCtD
Metformin—Urticaria—Ezetimibe—atherosclerosis	0.000179	0.00234	CcSEcCtD
Metformin—SLC47A1—adipose tissue—atherosclerosis	0.000179	0.00257	CbGeAlD
Metformin—Abdominal pain—Ezetimibe—atherosclerosis	0.000178	0.00233	CcSEcCtD
Metformin—Paraesthesia—Niacin—atherosclerosis	0.000177	0.00232	CcSEcCtD
Metformin—Feeling abnormal—Simvastatin—atherosclerosis	0.000177	0.00232	CcSEcCtD
Metformin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000177	0.00232	CcSEcCtD
Metformin—Dyspnoea—Niacin—atherosclerosis	0.000176	0.0023	CcSEcCtD
Metformin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000176	0.0023	CcSEcCtD
Metformin—Somnolence—Niacin—atherosclerosis	0.000176	0.0023	CcSEcCtD
Metformin—Paraesthesia—Pravastatin—atherosclerosis	0.000175	0.00228	CcSEcCtD
Metformin—Dyspepsia—Niacin—atherosclerosis	0.000174	0.00227	CcSEcCtD
Metformin—Dyspnoea—Pravastatin—atherosclerosis	0.000173	0.00227	CcSEcCtD
Metformin—Decreased appetite—Niacin—atherosclerosis	0.000172	0.00225	CcSEcCtD
Metformin—Dyspepsia—Pravastatin—atherosclerosis	0.000171	0.00224	CcSEcCtD
Metformin—Rash—Rosuvastatin—atherosclerosis	0.000171	0.00224	CcSEcCtD
Metformin—Dermatitis—Rosuvastatin—atherosclerosis	0.000171	0.00224	CcSEcCtD
Metformin—Urticaria—Simvastatin—atherosclerosis	0.000171	0.00224	CcSEcCtD
Metformin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00017	0.00223	CcSEcCtD
Metformin—Abdominal pain—Simvastatin—atherosclerosis	0.00017	0.00222	CcSEcCtD
Metformin—Headache—Rosuvastatin—atherosclerosis	0.00017	0.00222	CcSEcCtD
Metformin—Decreased appetite—Pravastatin—atherosclerosis	0.000169	0.00221	CcSEcCtD
Metformin—Fatigue—Pravastatin—atherosclerosis	0.000168	0.00219	CcSEcCtD
Metformin—Constipation—Pravastatin—atherosclerosis	0.000166	0.00218	CcSEcCtD
Metformin—Asthenia—Lovastatin—atherosclerosis	0.000165	0.00216	CcSEcCtD
Metformin—Pruritus—Lovastatin—atherosclerosis	0.000163	0.00213	CcSEcCtD
Metformin—Asthenia—Ezetimibe—atherosclerosis	0.000162	0.00212	CcSEcCtD
Metformin—Gastrointestinal pain—Niacin—atherosclerosis	0.000161	0.00211	CcSEcCtD
Metformin—Nausea—Rosuvastatin—atherosclerosis	0.000161	0.00211	CcSEcCtD
Metformin—Feeling abnormal—Pravastatin—atherosclerosis	0.00016	0.0021	CcSEcCtD
Metformin—Pruritus—Ezetimibe—atherosclerosis	0.00016	0.00209	CcSEcCtD
Metformin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000159	0.00208	CcSEcCtD
Metformin—Diarrhoea—Lovastatin—atherosclerosis	0.000157	0.00206	CcSEcCtD
Metformin—Urticaria—Niacin—atherosclerosis	0.000157	0.00205	CcSEcCtD
Metformin—Abdominal pain—Niacin—atherosclerosis	0.000156	0.00204	CcSEcCtD
Metformin—Urticaria—Pravastatin—atherosclerosis	0.000154	0.00202	CcSEcCtD
Metformin—Asthenia—Simvastatin—atherosclerosis	0.000154	0.00202	CcSEcCtD
Metformin—Diarrhoea—Ezetimibe—atherosclerosis	0.000154	0.00202	CcSEcCtD
Metformin—Abdominal pain—Pravastatin—atherosclerosis	0.000154	0.00201	CcSEcCtD
Metformin—Pruritus—Simvastatin—atherosclerosis	0.000152	0.00199	CcSEcCtD
Metformin—Dizziness—Lovastatin—atherosclerosis	0.000152	0.00199	CcSEcCtD
Metformin—SLC22A1—adipose tissue—atherosclerosis	0.000149	0.00214	CbGeAlD
Metformin—Dizziness—Ezetimibe—atherosclerosis	0.000149	0.00195	CcSEcCtD
Metformin—Diarrhoea—Simvastatin—atherosclerosis	0.000147	0.00193	CcSEcCtD
Metformin—Vomiting—Lovastatin—atherosclerosis	0.000146	0.00191	CcSEcCtD
Metformin—Rash—Lovastatin—atherosclerosis	0.000145	0.0019	CcSEcCtD
Metformin—Dermatitis—Lovastatin—atherosclerosis	0.000145	0.00189	CcSEcCtD
Metformin—Headache—Lovastatin—atherosclerosis	0.000144	0.00188	CcSEcCtD
Metformin—Vomiting—Ezetimibe—atherosclerosis	0.000143	0.00188	CcSEcCtD
Metformin—SLC22A3—adipose tissue—atherosclerosis	0.000143	0.00205	CbGeAlD
Metformin—Dizziness—Simvastatin—atherosclerosis	0.000142	0.00186	CcSEcCtD
Metformin—Rash—Ezetimibe—atherosclerosis	0.000142	0.00186	CcSEcCtD
Metformin—Dermatitis—Ezetimibe—atherosclerosis	0.000142	0.00186	CcSEcCtD
Metformin—Asthenia—Niacin—atherosclerosis	0.000142	0.00185	CcSEcCtD
Metformin—Headache—Ezetimibe—atherosclerosis	0.000141	0.00185	CcSEcCtD
Metformin—Pruritus—Niacin—atherosclerosis	0.00014	0.00183	CcSEcCtD
Metformin—Asthenia—Pravastatin—atherosclerosis	0.000139	0.00183	CcSEcCtD
Metformin—Pruritus—Pravastatin—atherosclerosis	0.000138	0.0018	CcSEcCtD
Metformin—Vomiting—Simvastatin—atherosclerosis	0.000137	0.00179	CcSEcCtD
Metformin—Nausea—Lovastatin—atherosclerosis	0.000137	0.00179	CcSEcCtD
Metformin—Rash—Simvastatin—atherosclerosis	0.000136	0.00177	CcSEcCtD
Metformin—Dermatitis—Simvastatin—atherosclerosis	0.000135	0.00177	CcSEcCtD
Metformin—Diarrhoea—Niacin—atherosclerosis	0.000135	0.00177	CcSEcCtD
Metformin—Headache—Simvastatin—atherosclerosis	0.000135	0.00176	CcSEcCtD
Metformin—Nausea—Ezetimibe—atherosclerosis	0.000134	0.00175	CcSEcCtD
Metformin—Diarrhoea—Pravastatin—atherosclerosis	0.000133	0.00174	CcSEcCtD
Metformin—Dizziness—Niacin—atherosclerosis	0.000131	0.00171	CcSEcCtD
Metformin—Dizziness—Pravastatin—atherosclerosis	0.000129	0.00168	CcSEcCtD
Metformin—Nausea—Simvastatin—atherosclerosis	0.000128	0.00167	CcSEcCtD
Metformin—Vomiting—Niacin—atherosclerosis	0.000126	0.00164	CcSEcCtD
Metformin—SLC47A1—liver—atherosclerosis	0.000126	0.0018	CbGeAlD
Metformin—Rash—Niacin—atherosclerosis	0.000125	0.00163	CcSEcCtD
Metformin—Dermatitis—Niacin—atherosclerosis	0.000124	0.00163	CcSEcCtD
Metformin—Headache—Niacin—atherosclerosis	0.000124	0.00162	CcSEcCtD
Metformin—Vomiting—Pravastatin—atherosclerosis	0.000124	0.00162	CcSEcCtD
Metformin—Rash—Pravastatin—atherosclerosis	0.000123	0.0016	CcSEcCtD
Metformin—Dermatitis—Pravastatin—atherosclerosis	0.000122	0.0016	CcSEcCtD
Metformin—Headache—Pravastatin—atherosclerosis	0.000122	0.00159	CcSEcCtD
Metformin—Nausea—Niacin—atherosclerosis	0.000117	0.00153	CcSEcCtD
Metformin—Nausea—Pravastatin—atherosclerosis	0.000115	0.00151	CcSEcCtD
Metformin—SLC22A1—liver—atherosclerosis	0.000105	0.0015	CbGeAlD
Metformin—SLC22A3—liver—atherosclerosis	0.0001	0.00144	CbGeAlD
Metformin—SLC22A3—Metabolism—APOA2—atherosclerosis	9.47e-06	0.000122	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG8—atherosclerosis	9.46e-06	0.000122	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LTA4H—atherosclerosis	9.46e-06	0.000122	CbGpPWpGaD
Metformin—ND1—Metabolism—LPL—atherosclerosis	9.4e-06	0.000121	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCG5—atherosclerosis	9.36e-06	0.000121	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CETP—atherosclerosis	9.27e-06	0.00012	CbGpPWpGaD
Metformin—ND1—Metabolism—GPX1—atherosclerosis	9.17e-06	0.000118	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—NOS3—atherosclerosis	9.16e-06	0.000118	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—NOS3—atherosclerosis	9.16e-06	0.000118	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—NOS3—atherosclerosis	9.16e-06	0.000118	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—LPA—atherosclerosis	9.04e-06	0.000116	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ALB—atherosclerosis	9.01e-06	0.000116	CbGpPWpGaD
Metformin—ND1—Metabolism—CD36—atherosclerosis	8.93e-06	0.000115	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KNG1—atherosclerosis	8.87e-06	0.000114	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AGTR1—atherosclerosis	8.82e-06	0.000114	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG8—atherosclerosis	8.82e-06	0.000114	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LTA4H—atherosclerosis	8.82e-06	0.000114	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—BGN—atherosclerosis	8.75e-06	0.000113	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOA5—atherosclerosis	8.66e-06	0.000112	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CETP—atherosclerosis	8.64e-06	0.000111	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—NOS3—atherosclerosis	8.61e-06	0.000111	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PLG—atherosclerosis	8.6e-06	0.000111	CbGpPWpGaD
Metformin—ND1—Metabolism—MTHFR—atherosclerosis	8.47e-06	0.000109	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—atherosclerosis	8.38e-06	0.000108	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—atherosclerosis	8.38e-06	0.000108	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—atherosclerosis	8.38e-06	0.000108	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PLA2G1B—atherosclerosis	8.34e-06	0.000107	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARA—atherosclerosis	8.3e-06	0.000107	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.26e-06	0.000106	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	8.17e-06	0.000105	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SOCS3—atherosclerosis	8.14e-06	0.000105	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALOX5—atherosclerosis	8.05e-06	0.000104	CbGpPWpGaD
Metformin—ND1—Metabolism—AGT—atherosclerosis	8.04e-06	0.000104	CbGpPWpGaD
Metformin—ND1—Metabolism—APOE—atherosclerosis	7.88e-06	0.000102	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—atherosclerosis	7.88e-06	0.000102	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP3—atherosclerosis	7.86e-06	0.000101	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF2—atherosclerosis	7.83e-06	0.000101	CbGpPWpGaD
Metformin—ND1—Metabolism—CAV1—atherosclerosis	7.81e-06	0.000101	CbGpPWpGaD
Metformin—ND1—Metabolism—APOA1—atherosclerosis	7.79e-06	0.0001	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.75e-06	9.99e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.62e-06	9.82e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOB—atherosclerosis	7.6e-06	9.79e-05	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	7.58e-06	9.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EDN1—atherosclerosis	7.48e-06	9.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG1—atherosclerosis	7.48e-06	9.64e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL5—atherosclerosis	7.42e-06	9.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—LPL—atherosclerosis	7.26e-06	9.35e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NAMPT—atherosclerosis	7.22e-06	9.31e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—LIPC—atherosclerosis	7.18e-06	9.25e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOC3—atherosclerosis	7.13e-06	9.2e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CG—atherosclerosis	7.11e-06	9.17e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—LDLR—atherosclerosis	7.09e-06	9.14e-05	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	7.06e-06	9.1e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PRKCG—atherosclerosis	7.05e-06	9.09e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—FABP4—atherosclerosis	7.03e-06	9.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LCAT—atherosclerosis	7.03e-06	9.06e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG1—atherosclerosis	6.97e-06	8.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PLG—atherosclerosis	6.95e-06	8.96e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CETP—atherosclerosis	6.92e-06	8.93e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOA4—atherosclerosis	6.9e-06	8.9e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SPP1—atherosclerosis	6.87e-06	8.86e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—atherosclerosis	6.86e-06	8.85e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP7A1—atherosclerosis	6.78e-06	8.74e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—INS—atherosclerosis	6.73e-06	8.68e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SCARB1—atherosclerosis	6.63e-06	8.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FABP4—atherosclerosis	6.55e-06	8.45e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LCAT—atherosclerosis	6.55e-06	8.45e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—atherosclerosis	6.54e-06	8.43e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PLG—atherosclerosis	6.48e-06	8.35e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOA4—atherosclerosis	6.43e-06	8.29e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	6.41e-06	8.27e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFB—atherosclerosis	6.36e-06	8.2e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP7A1—atherosclerosis	6.32e-06	8.14e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP27A1—atherosclerosis	6.27e-06	8.08e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMGCR—atherosclerosis	6.26e-06	8.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AGT—atherosclerosis	6.21e-06	8e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—atherosclerosis	6.17e-06	7.96e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—APOB—atherosclerosis	6.14e-06	7.92e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—atherosclerosis	6.14e-06	7.91e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—LEP—atherosclerosis	6.08e-06	7.84e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOE—atherosclerosis	6.08e-06	7.84e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CAV1—atherosclerosis	6.03e-06	7.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOA1—atherosclerosis	6.01e-06	7.75e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—atherosclerosis	5.98e-06	7.71e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—atherosclerosis	5.98e-06	7.71e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—atherosclerosis	5.98e-06	7.71e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—atherosclerosis	5.98e-06	7.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.98e-06	7.71e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLA2G2A—atherosclerosis	5.94e-06	7.66e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOA2—atherosclerosis	5.94e-06	7.66e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALOX5AP—atherosclerosis	5.94e-06	7.66e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALOX15—atherosclerosis	5.94e-06	7.66e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—NOS3—atherosclerosis	5.9e-06	7.61e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG5—atherosclerosis	5.87e-06	7.56e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP27A1—atherosclerosis	5.84e-06	7.53e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—atherosclerosis	5.81e-06	7.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—F2—atherosclerosis	5.73e-06	7.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—APOB—atherosclerosis	5.73e-06	7.38e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LPA—atherosclerosis	5.67e-06	7.3e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCA1—atherosclerosis	5.58e-06	7.2e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALOX15—atherosclerosis	5.54e-06	7.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLA2G2A—atherosclerosis	5.54e-06	7.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOA2—atherosclerosis	5.54e-06	7.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALOX5AP—atherosclerosis	5.54e-06	7.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—atherosclerosis	5.49e-06	7.07e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BGN—atherosclerosis	5.49e-06	7.07e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG5—atherosclerosis	5.47e-06	7.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOA5—atherosclerosis	5.43e-06	7e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—atherosclerosis	5.4e-06	6.96e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LPA—atherosclerosis	5.28e-06	6.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	5.23e-06	6.74e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—INS—atherosclerosis	5.2e-06	6.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.18e-06	6.68e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BGN—atherosclerosis	5.12e-06	6.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL2—atherosclerosis	5.11e-06	6.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOA5—atherosclerosis	5.06e-06	6.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALOX5—atherosclerosis	5.05e-06	6.51e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1—atherosclerosis	5.03e-06	6.48e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—atherosclerosis	4.95e-06	6.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLA2G1B—atherosclerosis	4.87e-06	6.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.86e-06	6.27e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.83e-06	6.22e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMOX1—atherosclerosis	4.79e-06	6.17e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SERPINE1—atherosclerosis	4.77e-06	6.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALOX5—atherosclerosis	4.71e-06	6.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOB—atherosclerosis	4.59e-06	5.91e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOS3—atherosclerosis	4.56e-06	5.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAMPT—atherosclerosis	4.53e-06	5.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.53e-06	5.84e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LIPC—atherosclerosis	4.5e-06	5.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOC3—atherosclerosis	4.47e-06	5.77e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—atherosclerosis	4.46e-06	5.75e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LDLR—atherosclerosis	4.45e-06	5.73e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—LPL—atherosclerosis	4.38e-06	5.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CETP—atherosclerosis	4.34e-06	5.6e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GPX1—atherosclerosis	4.27e-06	5.51e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAMPT—atherosclerosis	4.22e-06	5.44e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—atherosclerosis	4.21e-06	5.43e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—atherosclerosis	4.21e-06	5.43e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—atherosclerosis	4.21e-06	5.43e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LIPC—atherosclerosis	4.2e-06	5.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOC3—atherosclerosis	4.17e-06	5.38e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CD36—atherosclerosis	4.16e-06	5.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SCARB1—atherosclerosis	4.16e-06	5.36e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LDLR—atherosclerosis	4.14e-06	5.34e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CETP—atherosclerosis	4.05e-06	5.22e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—atherosclerosis	4.04e-06	5.21e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—atherosclerosis	3.96e-06	5.1e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—atherosclerosis	3.94e-06	5.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMGCR—atherosclerosis	3.93e-06	5.06e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SCARB1—atherosclerosis	3.88e-06	5e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARA—atherosclerosis	3.87e-06	4.99e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.85e-06	4.96e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AGT—atherosclerosis	3.75e-06	4.83e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOE—atherosclerosis	3.67e-06	4.73e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMGCR—atherosclerosis	3.66e-06	4.72e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—atherosclerosis	3.66e-06	4.71e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAV1—atherosclerosis	3.64e-06	4.69e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOA1—atherosclerosis	3.63e-06	4.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKB1—atherosclerosis	3.62e-06	4.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.59e-06	4.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK8—atherosclerosis	3.55e-06	4.58e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCA1—atherosclerosis	3.5e-06	4.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—atherosclerosis	3.31e-06	4.27e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—atherosclerosis	3.28e-06	4.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCA1—atherosclerosis	3.26e-06	4.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—atherosclerosis	3.25e-06	4.19e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—atherosclerosis	3.2e-06	4.12e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—INS—atherosclerosis	3.14e-06	4.04e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—atherosclerosis	3.1e-06	4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—atherosclerosis	3.01e-06	3.88e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMOX1—atherosclerosis	3e-06	3.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOB—atherosclerosis	2.88e-06	3.71e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—atherosclerosis	2.88e-06	3.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMOX1—atherosclerosis	2.8e-06	3.61e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.8e-06	3.61e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NOS3—atherosclerosis	2.75e-06	3.55e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LPL—atherosclerosis	2.75e-06	3.54e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—atherosclerosis	2.71e-06	3.5e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOB—atherosclerosis	2.68e-06	3.46e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPX1—atherosclerosis	2.68e-06	3.45e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CD36—atherosclerosis	2.61e-06	3.36e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—atherosclerosis	2.61e-06	3.36e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LPL—atherosclerosis	2.56e-06	3.3e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—atherosclerosis	2.52e-06	3.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX1—atherosclerosis	2.5e-06	3.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—atherosclerosis	2.47e-06	3.19e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CD36—atherosclerosis	2.43e-06	3.14e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARA—atherosclerosis	2.43e-06	3.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AGT—atherosclerosis	2.35e-06	3.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—atherosclerosis	2.31e-06	2.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOE—atherosclerosis	2.3e-06	2.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAV1—atherosclerosis	2.28e-06	2.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOA1—atherosclerosis	2.28e-06	2.93e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—atherosclerosis	2.27e-06	2.93e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARA—atherosclerosis	2.26e-06	2.92e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AGT—atherosclerosis	2.19e-06	2.82e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOE—atherosclerosis	2.15e-06	2.77e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAV1—atherosclerosis	2.13e-06	2.74e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOA1—atherosclerosis	2.12e-06	2.74e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—atherosclerosis	2.09e-06	2.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—atherosclerosis	2.08e-06	2.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—atherosclerosis	2.01e-06	2.59e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—INS—atherosclerosis	1.97e-06	2.54e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.94e-06	2.5e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—atherosclerosis	1.87e-06	2.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—INS—atherosclerosis	1.83e-06	2.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—atherosclerosis	1.8e-06	2.32e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NOS3—atherosclerosis	1.73e-06	2.22e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—atherosclerosis	1.68e-06	2.17e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NOS3—atherosclerosis	1.61e-06	2.07e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.58e-06	2.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—atherosclerosis	1.47e-06	1.9e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—atherosclerosis	1.26e-06	1.63e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—atherosclerosis	7.93e-07	1.02e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—atherosclerosis	7.39e-07	9.53e-06	CbGpPWpGaD
